Immunoendocrine Dysregulation during Gestational Diabetes Mellitus: The Central Role of the Placenta.
Andrea Olmos-OrtízMaría Del Pilar Flores-EspinosaLorenza Díaz-NietoPilar VelázquezCarlos Ramírez-IsarrarazVerónica Zaga-ClavellinaPublished in: International journal of molecular sciences (2021)
Gestational Diabetes Mellitus (GDM) is a transitory metabolic condition caused by dysregulation triggered by intolerance to carbohydrates, dysfunction of beta-pancreatic and endothelial cells, and insulin resistance during pregnancy. However, this disease includes not only changes related to metabolic distress but also placental immunoendocrine adaptations, resulting in harmful effects to the mother and fetus. In this review, we focus on the placenta as an immuno-endocrine organ that can recognize and respond to the hyperglycemic environment. It synthesizes diverse chemicals that play a role in inflammation, innate defense, endocrine response, oxidative stress, and angiogenesis, all associated with different perinatal outcomes.
Keyphrases
- oxidative stress
- endothelial cells
- pregnant women
- insulin resistance
- immune response
- pregnancy outcomes
- diabetic rats
- ischemia reperfusion injury
- dna damage
- type diabetes
- adipose tissue
- vascular endothelial growth factor
- induced apoptosis
- high glucose
- metabolic syndrome
- high fat diet
- high intensity
- skeletal muscle
- glycemic control
- signaling pathway
- wound healing
- high fat diet induced
- innate immune
- weight loss
- drug induced
- heat stress